Cargando…
Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway
Non-small cell lung cancer (NSCLC), which accounts for more than 80% of lung cancers, is a leading cause of cancer mortality worldwide. However, the mechanism underlying its progression remains unclear. Here we found that HIC1 promoter was heavily methylated in NSCLC cell lines and tissues contribut...
Autores principales: | Wang, Xiumin, Wang, Yingying, Xiao, Gang, Wang, Jinglong, Zu, Lidong, Hao, Mingang, Sun, Xueqing, Fu, Yujie, Hu, Guohong, Wang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058685/ https://www.ncbi.nlm.nih.gov/pubmed/27107418 http://dx.doi.org/10.18632/oncotarget.8734 |
Ejemplares similares
-
CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms
por: Xiao, Gang, et al.
Publicado: (2015) -
Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer
por: Sun, Xueqing, et al.
Publicado: (2019) -
Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma
por: Wu, Wenyi, et al.
Publicado: (2016) -
Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression
por: Wu, Tianqi, et al.
Publicado: (2022) -
Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer
por: Nicoll, G, et al.
Publicado: (2001)